ARCHIVES

FDA Approves Taxotere And Gemzar; Sends Approvable Letter For Etopophos

This article is from The Cancer Letter archive.

Vol. 22 No. 21 | May 24, 1996

Download PDF Visit The Full Archive

Related Articles

NCI Plans Briefing Oct. 8 In St. Louis for SPORE Applicants

August 23, 1991

Conference Bill Includes Funding For DOD For Breast, Prostate, Ovarian Cancer

October 4, 1996

In Brief: WHI Revises Protocol After Study Finds High Rate Of Endometrial Hyperplasia

January 27, 1995

Aromasin Approved By FDA For ER+ Early Breast Cancer

October 28, 2005

House panel examines use of grant funds.

September 23, 2005

Organ Systems Program to Submit 10 More Concepts In Fall

July 10, 1987